Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state.

Furth N, Pateras IS, Rotkopf R, Vlachou V, Rivkin I, Schmitt I, Bakaev D, Gershoni A, Ainbinder E, Leshkowitz D, Johnson RL, Gorgoulis VG, Oren M, Aylon Y.

Life Sci Alliance. 2018 Oct 30;1(5):e201800171. doi: 10.26508/lsa.201800171. eCollection 2018 Oct.

2.

Cultural values, coping, and hope in Yup'ik communities facing rapid cultural change.

Rivkin I, Lopez EDS, Trimble JE, Johnson S, Orr E, Quaintance T.

J Community Psychol. 2018 Nov 8. doi: 10.1002/jcop.22141. [Epub ahead of print]

PMID:
30407637
3.

Systemic and individual factors in the buprenorphine treatment-seeking process: a qualitative study.

Hewell VM, Vasquez AR, Rivkin ID.

Subst Abuse Treat Prev Policy. 2017 Jan 11;12(1):3. doi: 10.1186/s13011-016-0085-y.

4.

Treatment of respiratory damage in mice by aerosols of drug-encapsulating targeted lipid-based particles.

Rivkin I, Galnoy-Glucksam Y, Elron-Gross I, Afriat A, Eisenkraft A, Margalit R.

J Control Release. 2017 Jul 10;257:163-169. doi: 10.1016/j.jconrel.2016.03.039. Epub 2016 Apr 5.

PMID:
27059722
5.

Cancer cell sensitization and improved treatment efficacy by combined sodium butyrate and paclitaxel formulations is cancer-type specific.

Rivkin I, Cohen K, Bod T, Argov M, Margalit R.

Int J Pharm. 2014 Jan 30;461(1-2):437-47. doi: 10.1016/j.ijpharm.2013.12.021. Epub 2013 Dec 24.

PMID:
24370842
6.

Disseminating research in rural Yup'ik communities: challenges and ethical considerations in moving from discovery to intervention development.

Rivkin I, Trimble J, Lopez ED, Johnson S, Orr E, Allen J.

Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.20958. eCollection 2013.

7.

Continuing education training focused on the development of behavioral telehealth competencies in behavioral healthcare providers.

Gifford V, Niles B, Rivkin I, Koverola C, Polaha J.

Rural Remote Health. 2012;12:2108. Epub 2012 Dec 17.

8.

Providers' voices on telebehavioral health: survey of an outpatient counseling agency in Alaska.

Ford T, Avey J, Deruyter J, Whipple JL, Rivkin I.

Psychol Serv. 2012 Aug;9(3):316-7. doi: 10.1037/a0026154.

PMID:
22867124
9.

Screening for cervical neoplasia: a community-based trial comparing Pap staining, human papilloma virus testing, and the new bi-functional Celldetect® stain.

Idelevich P, Kristt D, Schechter E, Lew S, Elkeles A, Terkieltaub D, Rivkin I, Bruchim I, Fishman A.

Diagn Cytopathol. 2012 Dec;40(12):1054-61. doi: 10.1002/dc.21729. Epub 2011 May 31.

PMID:
21630482
10.

Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia.

Idelevich P, Elkeles A, Okon E, Kristt D, Terkieltaub D, Rivkin I, Bruchim I, Fishman A.

Diagn Pathol. 2010 Nov 11;5:70. doi: 10.1186/1746-1596-5-70.

11.

Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors.

Rivkin I, Cohen K, Koffler J, Melikhov D, Peer D, Margalit R.

Biomaterials. 2010 Sep;31(27):7106-14. doi: 10.1016/j.biomaterials.2010.05.067. Epub 2010 Jun 17.

PMID:
20619792
12.

Value of Community Partnership for Understanding Stress and Coping in Rural Yup'ik Communities: The CANHR Study.

Rivkin ID, Lopez E, Quaintance TM, Trimble J, Hopkins S, Fleming C, Orr E, Mohatt GV.

J Health Dispar Res Pract. 2010;4(3):2.

13.

A color discriminating broad range cell staining technology for early detection of cell transformation.

Sagiv I, Idelevich P, Rivkin I, Margalit R, Elkeles A, Levitzki A.

J Carcinog. 2009;8:16. doi: 10.4103/1477-3163.58372.

14.

Three-dimensional characterization of drug-encapsulating particles using STEM detector in FEG-SEM.

Barkay Z, Rivkin I, Margalit R.

Micron. 2009 Jun;40(4):480-5. doi: 10.1016/j.micron.2008.12.003. Epub 2008 Dec 24.

PMID:
19167897
15.

Risk reduction for HIV-positive African American and Latino men with histories of childhood sexual abuse.

Williams JK, Wyatt GE, Rivkin I, Ramamurthi HC, Li X, Liu H.

Arch Sex Behav. 2008 Oct;37(5):763-72. doi: 10.1007/s10508-008-9366-5.

16.

Electrochemical lab on a chip for high-throughput analysis of anticancer drugs efficiency.

Popovtzer R, Neufeld T, Popovtzer A, Rivkin I, Margalit R, Engel D, Nudelman A, Rephaeli A, Rishpon J, Shacham-Diamand Y.

Nanomedicine. 2008 Jun;4(2):121-6. doi: 10.1016/j.nano.2008.03.002. Epub 2008 May 14.

PMID:
18482873
17.

Substance abuse and medication adherence among HIV-positive women with histories of child sexual abuse.

Liu H, Longshore D, Williams JK, Rivkin I, Loeb T, Warda US, Carmona J, Wyatt G.

AIDS Behav. 2006 May;10(3):279-86.

18.

Severity of child sexual abuse, post- traumatic stress and risky sexual behaviors among HIV-positive women.

Myers HF, Wyatt GE, Loeb TB, Carmona JV, Warda U, Longshore D, Rivkin I, Chin D, Liu H.

AIDS Behav. 2006 Mar;10(2):191-9.

PMID:
16479413
19.

The effects of expressive writing on adjustment to HIV.

Rivkin ID, Gustafson J, Weingarten I, Chin D.

AIDS Behav. 2006 Jan;10(1):13-26.

PMID:
16421649
20.

The efficacy of an integrated risk reduction intervention for HIV-positive women with child sexual abuse histories.

Wyatt GE, Longshore D, Chin D, Carmona JV, Loeb TB, Myers HF, Warda U, Liu H, Rivkin I.

AIDS Behav. 2004 Dec;8(4):453-62.

PMID:
15690118
21.

Child sexual abuse: associations with the sexual functioning of adolescents and adults.

Loeb TB, Williams JK, Carmona JV, Rivkin I, Wyatt GE, Chin D, Asuan-O'Brien A.

Annu Rev Sex Res. 2002;13:307-45. Review.

PMID:
12836735
22.

Harnessing the imagination. Mental simulation, self-regulation, and coping.

Taylor SE, Pham LB, Rivkin ID, Armor DA.

Am Psychol. 1998 Apr;53(4):429-39.

PMID:
9572006
23.
24.
25.

Inhibition of in vitro neutrophil chemotaxis and spontaneous motility by anti-inflammatory agents.

Rivkin I, Foschi GV, Rosen CH.

Proc Soc Exp Biol Med. 1976 Nov;153(2):236-40. No abstract available.

PMID:
995953
26.

Effect of exogenous cyclic AMP and other adenine nucleotides on neutrophil chemotaxis and motility.

Rivkin I, Becker EL.

Int Arch Allergy Appl Immunol. 1976;50(1):95-102.

PMID:
171225
27.

Lack of steroidogenic response to cyclic AMP and ACTH in adrenal cells from rats bearing the MtTF4 tumor.

Rivkin I, Chasin M.

Arch Int Pharmacodyn Ther. 1975 Oct;217(2):309-21.

PMID:
172038
29.

Alpha- and beta-adrenergic receptors as mediators of accumulation of cyclic adenosine 3',5'-monophosphate in specific areas of guinea pig brain.

Chasin M, Rivkin I, Mamrak F, Samaniego SG, Hess SM.

J Biol Chem. 1971 May 10;246(9):3037-41. No abstract available.

30.

Nucleotide specificity of the steroidogenic response of rat adrenal cell suspensions prepared by collagenase digestion.

Rivkin I, Chasin M.

Endocrinology. 1971 Mar;88(3):664-70. No abstract available.

PMID:
4322384

Supplemental Content

Loading ...
Support Center